The use of angiotensin-converting enzyme inhibitors and other drugs with cardiovascular effects by non-demented and demented elderly with a clinical diagnosis of heart failure. A population-based study of the very old

Author： Klarin Inga   Fastbom Johan   Wimo Anders  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.62, Iss.7, 2006-07, pp. : 555-562

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cost of Heart Failure in Patients Receiving -Blockers and Angiotensin-Converting Enzyme Inhibitors

By Weintraub W.S.  

Clinical Drug Investigation, Vol. 24, Iss. 5, 2004-01 ,pp. : 255-264

Adis International

Access to resources Recommend Favorite

Angiotensin Converting Enzyme (ACE) Inhibitors and Heart Failure: The Consequences of Underprescribing

By Andersson F.  

PharmacoEconomics, Vol. 15, Iss. 6, 1999-06 ,pp. : 535-550

Adis International

Access to resources Recommend Favorite

Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium

By Lenz O.   Schmid B.   Kilter H.   La Rosee K.   Flesch M.   Kuhn-Regnier F.   Sudkamp M.   Bohm M.  

European Journal of Pharmacology, Vol. 294, Iss. 1, 1995-01 ,pp. : 17-27

Elsevier

Access to resources Recommend Favorite

Safety issues associated with the use of angiotensin-converting enzyme inhibitors

By Ehlers Mario R  

Expert Opinion on Drug Safety, Vol. 5, Iss. 6, 2006-11 ,pp. : 739-740

Informa Healthcare

Access to resources Recommend Favorite

Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin

By Pham I.   Gonzalez W.   Doucet J.   Fournie-Zaluski M.-C.   Roques B.P.   Michel J.-B.  

European Journal of Pharmacology, Vol. 296, Iss. 3, 1996-02 ,pp. : 267-276

Elsevier

Access to resources Recommend Favorite